<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Pharmalicensing.com: Industry news</title>
		<link>http://pharmalicensing.com/rss/</link>
		<description>Latest market and business intelligence from the leading publishers worldwide.</description>
		<language>en-us</language>
		<image>
			<title>Pharmalicensing.com: Industry news</title>
			<link>http://pharmalicensing.com/rss/</link>
			<url>http://pharmalicensing.com/images/pharmalicensing_logo.gif</url>
			<width>144</width>
		</image>
								<item>
				<title>SRI International and F. Hoffmann-La Roche Launch Translational Medicine Collaboration to Study Methods and Treatments Associated with Cognitive Deficits across Neuropsychiatric Disorders</title>
				<description>MENLO PARK, Calif.--November 10, 2009--SRI International, an independent nonprofit research and development organization, announced today that its Center for Neuroscience has entered into a research...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/499647/0/14/sri-international-and-f-hoffmann-la-roche-launch-translational-medicine-collaboration-to-study-methods-and-treatments-associated-with-cognitive-deficits-across-neuropsychiatric-disorders</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/499647/0/14/sri-international-and-f-hoffmann-la-roche-launch-translational-medicine-collaboration-to-study-methods-and-treatments-associated-with-cognitive-deficits-across-neuropsychiatric-disorders</guid>
			</item>
					<atom:link href="http://pharmalicensing.com/public/public/news/latest/0/14.rss" rel="self" type="application/rss+xml" />
	</channel>
</rss>
